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ABSTRACT 
Background and aims: Type 1 diabetes (T1DM) affects young people during the most active years 
of their life. Our aim was to assess quality of life (QoL) and associated variables in a large cohort  of 
adults with childhood-onset and adult-onset T1DM. 
Methods: A cohort of adult patients (18 years and older) from the T1DM Registry of Turin, Italy, 
was recruited. Clinical characteristics and Diabetes QoL (DQOL) questionnaire were assessed by 
standardized procedures.  
Results: 310 adults completed the questionnaire. Age and diabetes duration at assessment (mean ± 
SD) were 32.8±7.3 years and 17.3±6.3 years, respectively. DQOL and its subscores were in the 
lower quartiles of their distributions, indicating a good level of QoL. However, scores were 
significantly higher in females than in males, particularly for the subscale of diabetes-related 
worries. In multivariate analysis, lower QoL was independently associated with female sex (β=1.07, 
95% CI 1.03-1.11, p=0.003), higher age at onset (β=1.03, 1.00-1.05, p=0.009), lower schooling 
(β=1.05, 1.00-1.09, p=0.02), higher fasting plasma glucose (β=1.03, 1.01-1.05, p=0.008), daily 
SMBG >4 (β=1.06, 1.01-1.10, p=0.01), severe hypoglycemia over the last year (β=1.06, 1.01-1.11, 
p=0.02), lower numbers of diabetologic visits (β=1.07, 1.01-1.13, p=0.02) and hypertension 
(β=1.06, 1.02-1.10, p=0.005). Autonomic neuropathy was associated with diabetes impact. Female 
sex (β=4.36, 2.43-7.83) and daily SMBG >4 (β=3.77, 1.72-8.30) were independently associated with 
worst level and CSII with better level (β=0.22, 0.07-0.68) of  diabetes-related worries. 
Conclusions: The impact of T1DM on QoL may depend on demographic, metabolic control-related 
variables, presence of complications and insulin delivery modality. 
 
        Type 1 diabetes (T1DM) is a chronic disease affecting young people and influencing the most 
active years of their life. Current management of T1DM includes self-monitoring of blood glucose 
(SMBG) and multiple insulin injections under the constant threat of hypoglycemic events and 
chronic complications (1, 2). The results of the Diabetes Control and Complications Trial (DCCT) 
focused on the effectiveness of maintaining blood glucose levels as close as possible to the normal 
range to prevent or delay microvascular complications (3). To do so, patients need appropriate 
knowledge and skills to make informed choices and behavioural changes (4). Understandably, they 
feel challenged by diabetes and its day-to-day demands, as they have to make countless decisions 
for their metabolism to approximate the non-diabetic state. As a result, the psychosocial toll of 
living with diabetes is a heavy one, possibly reflecting on self-care behavior and quality of life  
(QoL) (1-2). 
      Previous reports on QoL in T1DM have either included relatively small numbers of young 
patients or limited recruitment to childhood-onset T1DM (5-11). The impact of the disease, 
however, might differ by both age and age at onset of the disease. The Turin Registry has been 
recruiting incident cases of T1DM in the age group 0-29 years since 1984 (12), and a wide 
population-based cohort is now available for morbidity (13) and mortality studies (14). Aim of this 
study was to assess self-reported QoL and its association with demographic and health-related data 




     The first Italian population-based registry of T1DM was established in 1984 in Turin, Northern 
Italy, to monitor the incidence rate of the disease up to age 29 years. As previously described, 1053 
incident cases were recruited between 1/1/1984 and 12/31/2000 (14). Since we estimated from 
Registry data that the regional pediatric hospital had been the referral center for more than 95% of 
children of the Province of Turin, we further identified a hospital-based cohort of incident cases of 
T1DM aged 0-14 years at diagnosis in the period 1974-1983 (n=157), approximating it to a 
population-based cohort.  Therefore, the final incident cohort included 1210 patients with onset of 
T1DM in period 1974-2000.  
Recruitment of the cohort 
    In January 2004, a follow-up investigation was set up in order to ascertain life status of all 
members of the overall cohort (14). Out of 1210 incident cases, 1113 were still living in the 
Province of Turin and formed the study base for the morbidity study (13). In this paper, data 
referring to 1039 patients aged 18 years and over at the clinical examination (2006-2007) were 
analysed. In the first phase of recruitment, the registry contacted the diabetologists who had 
performed the initial diagnosis in order to obtain active consent to recruit their patients (acceptance 
rate=98%). In the second phase, a letter indicating the aims of the study, their diabetologist’s 
consent and an invitation to contact our diabetes clinic was sent to all patients. Those who did not 
answer the letter within two weeks were then called by phone either by their diabetologists or by 
ourselves every fortnight for up to three times to plan an appointment. To further increase adherence 
to the study, the list of non-recruited patients was re-examined by all diabetologists in search for any 
who had been seen over the previous months. The response rate of adult patients with T1DM was 
33% (343/1039). 
Examination of the cohort 
     The study was approved by the local ethics committee and carried out in accordance with the 
principles of the Helsinki Declaration. All adult patients who provided written consent (343/1039) 
were examined in 2006-2007 by trained investigators who performed fundus examination, a 12-lead 
resting ECG and tests for autonomic and peripheral neuropathy. For each patient we collected, by 
standardized procedures, demographic data, schooling level, smoking habits, daily alcohol intake 
(grams per day), current insulin therapy, number and units of daily insulin administrations, 
frequency of SMBG, any previous hospitalization due to diabetes, any hypoglycemic event serious 
enough to require the help of another person and the number of diabetologic visits over the previous 
12 months.  
All blood specimens were centrally analyzed, including measurements of HbA1c and plasma lipids. 
Blood pressure was measured twice while recumbent (after 10-min rest and 2-min apart), and 1 min 
and 2 min after standing up. Hypertension was defined as systolic blood pressure ≥140 mmHg or 
diastolic blood pressure ≥90 mmHg. BMI was calculated as kg/m2  and overweight and obesity 
defined by values between 26 and 29 kg/m2 and 30 kg/m2 and over, respectively. Microvascular 
complications were defined by standardized procedures, according to the EURODIAB protocol (15). 
Retinopathy was assessed by retinal photographs taken according to the EURODIAB protocol and 
graded by one diabetologist expert in diabetic retinopathy (MP) and classified as absent (level 0), 
non-proliferative (levels 1-3 for mild, moderate or severe), proliferative (level 4) and maculopathy. 
Nephropathy was defined as either overnight albumin excretion rate (AER) ≥20µg/min or 
albumin/creatinine ratio (A/C) ≥30 μg/mg on a spot urine sample. No patient had end-stage renal 
disease. Cardiovascular disease (CVD) was considered as the composite of any documented episode 
of myocardial infarction, stable or unstable angina, lower limb peripheral arteriopaty, and 
hemodinamically significant stenosis of epiaortic vessels.  
Quality of life ascertainment 
    Perception of QoL was assessed by the self-administered Diabetes QoL (DQOL) questionnaire 
translated and validated into Italian (16, 17). The DQOL questionnaire was designed by the DCCT 
Research Group and contains 46 items which the patient rank on 5-point Likert scales ranging from 
1 to 5 (1=never, 5=all the time). Four subscales measure diabetes impact on daily life (20 items, 
range 20-200), diabetes-related worries (4 items, range 4-20), satisfaction (15 items, range 15-75), 
and social worries (7 items, range 7-35). The DQOL score is the algebraic sum of the four scores 
and ranges between the minimum value of 46, corresponding to the highest level of quality of life, 
and a maximum of 230, corresponding to the lowest level of quality of life. This instrument has 
good evidence of reliability and internal and external validity, both for the original version (16) and 
the Italian translation (17).  
Statistical analysis 
    Normally distributed variables are presented as mean ± standard deviation (SD), whereas 
variables with skewed distribution (DQOL and its subscales) were analyzed after logarithmic 
transformation and the results presented as geometric means and interquartile range. Differences in 
clinical characteristics of patients were assessed by t test for continuous variables and χ2 test for 
categorical ones. P-values refer to differences for either log-transformed DQOL score or its 
subscores among different groups of comparison. Pearson’s correlation coefficients between 
continuous variables and log-transformed DQOL and subscales scores were performed. 
     We then performed multivariate linear regression analysis to assess variables independently 
associated with DQOL (total and subscales). On the basis of a a priori hypothesis, we assessed 
nested models examining the associations of DQOL with metabolic control-related variables and 
complications, taking into account the role of demographic variables as potential confounders. Both 
backward and forward strategies of model selection were employed and variables retained if they 
added significantly to the model or to the estimated coefficients of predictors. Examined variables 
were age, age at onset, duration of diabetes, fasting plasma glucose, HbA1c, lipids, BMI (continuous 
variable), sex, schooling (primary school vs secondary school or higher), microvascular 
complications, numbers of daily insulin injections (<4 and ≥4), daily SMBG (0-4 and >4), previous 
hospitalizations (yes vs no), use of continuous subcutaneous insulin infusion (CSII), number of 
diabetologic visits over the previous 12 months (≤2, >2), severe hypoglycemic episodes over the 
previous 12 months (yes vs no). For continuous variables (fasting plasma glucose, age and age at 
onset of T1DM) β values for each increment of 1 SD are shown in Table 3. Analyses were 
performed with STATA software, version 10.0.  
Results 
         Out of the incident cohort, 343 adults were recruited, 310 of whom correctly completed the 
DQOL questionnaire and were included in the analysis. Among 696 non-recruited adults, 410 
(58.9%) could not be traced, 214 (30.8%) were not interested in the study and 72 (10.3%) had 
difficulties in obtaining leave of absence from work. Compared to recruited people, they were 
similar with respect to sex, age, age at diagnosis  and diabetes duration (data not shown). 
        Patients included in the analyses (n=310, 53.5% males) had mean age at follow-up of 32.8 ± 
7.3 years (range 19.5-48.6 years) and  mean duration of diabetes of 17.3 ± 6.3 years (range 5.9-32.0 
years), 144 (46.5%) of them were aged 0-14 years and 166 (53.5%) 15-29 years at diabetes onset. 
Fasting plasma glucose and  HbA1c were 184.5± 85.8 mg/dl and 8.4±1.3%, respectively, with 36 
subjects (11.6%) having HbA1c values <7.0%. Multiple daily insulin injections (≥4) were used by 
95.2% of the cohort, and out of them 32 (10.3% of the cohort) used CSII. Mean values of systolic 
and diastolic blood pressure were 114 ± 12.2 and 79.0 ± 8.6 mmHg, respectively, and 29.7% of the 
patients were hypertensive. Most of the patients had normal weight, whereas 25.5% were 
overweight  and 5.5% were obese. Ten patients (3.2%) had CVD, 137 (44.2%) any grade diabetic 
retinopathy, 56 (18.1%) micro-macroalbuminuria, 34 (11.0%) peripheral neuropathy and 52  
(16.8%) autonomic neuropathy. With regard to schooling, 83 (26.8%) patients had attended  primary 
school and 227 (73.2%) secondary school or higher.  
      As shown in Table 1, scores of DQOL and its subscales were in the lower quartiles of their 
distributions, indicating a fairly good level of perceived QoL. Values, however, were significantly 
higher in females than in males for both DQOL and subscales referring to diabetes impact, diabetes-
related worries and social worries.  
        DQOL correlated positively with age at onset (r=0.15, p=0.009), daily frequency of SMBG 
(r=0.25, p<0.0001), fasting blood glucose (r=0.18, p=0.001) and HbA1c (r=0.13, p=0.02). In 
addition, the number of severe hypoglycemic episodes over the previous year correlated positively 
with the subscale of diabetes impact (r=0.12, p=0.02).  
Scores referring to diabetes-related worries were positively associated with daily SMBG (r=0.29, 
p<0.0001) and negatively associated with the number of daily insulin injections (r= -0.14, p=0.02). 
The scores of satisfaction were positively associated with age (r=0.14, p=0.02), HbA1c (r=0.22, 
p<0.0001), fasting glucose (r=0.16, p=0.005), daily SMBG (r=0.12, p=0.05) and diastolic blood 
pressure (r=0.11, p=0.06). The scores referring to social worries were associated negatively with age 
(-0.13, p=0.02) and positively with daily SMBG (r=0.13, p=0.03).  
        As shown in Table 2, other variables associated with higher DQOL in univariate analyses were 
both peripheral (p=0.02) and autonomic neuropathy (p=0.01), ≤2 diabetologic visits vs >2 over the 
previous year and low educational level (p<0.001). Neither retinopathy nor hospitalizations due to 
diabetes were associated with DQOL (data not shown). Similar results were found for other 
subscales, apart from satisfaction, which was also associated with hypertension (p=0.009) (online 
Table 1). 
        In multivariate analysis (Table 3), higher DQOL scores were positively and independently 
associated with demographic variables (sex, age at onset, low educational level), diabetes control-
related factors (fasting plasma glucose, severe hypoglycemia over the previous year, 2 and less 
diabetologic visits over the previous year, daily SMBG >4), and complications (hypertension). Other 
microvascular and cardiovascular complications did not add significantly to the model, either 
separately or as a composite variable. This model explained 17% of the entire variability. We then 
performed separate models for each DQOL subscale (online Table 2). Results were similar using 
diabetes impact as dependent variable, apart from the number of diabetologic visits, which was no 
longer significant, and autonomic neuropathy, which was significantly associated. In contrast, 
diabetes-related worries showed a strong positive association with female sex (β=4.36, 2.43-7.83) 
and daily SMBG >4 (β=3.77, 1.72-8.30), whereas CSII was negatively associated (β=0.22, 0.07-
0.68). With regard to satisfaction, associated variables were female sex, fasting plasma glucose, 2 or 
less diabetologic visits over the last year, hypertension and low schooling. Social worries were 
associated negatively with age and positively with daily SMBG >4 and autonomic neuropathy.  
 
Discussion 
      Integrating diabetes into one’s life and self-identity is a complex and challenging process, which 
poses considerable demands on people’s coping, self-esteem and mood (18, 19). This paper suggests 
that, in spite of all the above demands, T1DM may not play a markedly detrimental role in the life of 
adult patients, at least in the case of males, whereas females appear to be marginally more 
vulnerable to the pressures of the disease on their QoL, with specific reference to diabetes impact, 
diabetes-related worries and social worries. In any event, the average scores and interquartile ranges 
for all subareas of the DQOL, a tool that was specifically designed for patients with T1DM enrolled 
in the DCCT (16), are within the first quartile of the available ranges, connected with acceptably 
good QoL. Being a disease-specific questionnaire, the DQOL does not allow direct comparisons 
between diabetic and non diabetic persons. Similarly, there are no normal ranges for DQOL reported 
in the literature, whether in overall diabetic population samples or in specific age groups of patients. 
Our study was performed in adult patients, whereas previous studies using the DQOL questionnaire 
to analyze QoL in diabetic patients had limited recruitment to children and adolescents. Nonetheless, 
associations among QoL and the variables examined in our study were similar to those observed in 
studies of younger patients. In particular, they showed lower QoL in girls than boys and in older 
adolescents, and higher QoL in patients using insulin pumps (20-24). A recent study compared QoL  
through the KINDL-R questionnaire in diabetic people aged 11-17 with onset of disease at age 4 and 
lower and in a large control group of non diabetic people, providing evidence of similar scores of 
QoL in both groups (7). In our study, variables associated with worse quality of life were: having 
developed diabetes later in life, lower schooling, higher fasting blood glucose, more frequent 
SMBG, and having had severe hypoglycemic attacks and less diabetes consultations over the 
previous year. Interestingly, HbA1c levels were not associated with QoL, and only a small 
percentage of the patients had values <7%, which is far from recommendations of scientific societies 
guidelines (25). The literature is not consistent on the association of QoL with metabolic control, 
with some studies showing no correlation and others showing lower QoL in those with worse 
glycemic control ( 20-24). 
The influence of chronic complications was negligible, with the exception of autonomic neuropathy. 
The size of the effects of the above associations on overall QoL, however, was fairly small, and 
diabetes-related worries was the only subarea that showed large fourfold effects of being female and 
doing more frequent SMBG whereas, interestingly, being on CSII was associated with a similarly 
sized improvement of the score. It remains to be established whether better QoL was a result of 
these technical opportunities or rather it was patients with different psychological characteristics 
who availed themselves of these practices.  
        The results of this survey do suggest that patients in our area receive satisfactory support from 
the local network of diabetes clinics. There is however scope for further improvement, by 
implementing new approaches to care which involve a major redefinition of the roles and 
relationships between health care professionals and patients (2). In a previous study, we measured 
similar DQOL scores in adult patients with T1DM followed by usual care and an improvement after 
3 years of an approach which substituted traditional top-down one-to-one visits with interactive 
group education sessions (26). Further addition of a structured carbohydrate counting programme 
improved not only QoL but also HbA1c and coping skills (27). 
      Limitations of this study include its cross-sectional design, which does not allow to draw causal 
relationships between perceived QoL and associated factors. Secondly, selection bias cannot be 
ruled out, as people who were not recruited in spite of proactive strategies to increase the response 
rate may include a higher proportion of either highly active individuals, possibly with a better QoL, 
or people with negative perceptions of their disease and/or invalidating complications and worse 
QoL. Although previous cross-sectional studies on young T1DM reported higher overall response 
rates, they were performed either in clinic-based cohorts (23) or through administrative data (28). 
When active participation to a protocol was requested with a population-based approach, response 
rates were similar to ours (29-30). Conversely, strengths of our survey include being based upon a 
population incidence registry, which allowed to check for differences between recruited and non 
recruited individuals. In addition, to our knowledge, this is one of the largest studies of QoL 
perception among young adult people with T1DM. The DCCT had reportedly measured QoL by the 
DQOL tool (3), but detailed results were not published. Other studies that addressed the issue were 
either based on smaller samples or cohorts of childhood-onset T1DM aged <18 years  at recruitment 
(5-11).  
      In conclusion, this study suggests that QoL may be acceptably good in patients with T1DM, 
although females and patients with specific problems may fare worse. If confirmed in other cohorts, 
this suggests that strategies should be put in place to address the residual problems of a 
disadvantaged population by training providers to treat not only the pathophysiology of diabetes but 
also the psychosocial aspects of daily life with the disease. Our experience (21, 22) and that of 
others support the notion that, by empowering patients in their efforts to self-manage their diabetes 
and address psychological barriers, education and psychological care are instrumental in achieving 
more satisfactory medical and emotional outcomes.  
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Table 1: DQOL and subscales scores among 310 adults recruited by the T1DM Registry of Turin. Values are geometric mean and 
interquartile range. Higher scores indicate  worse quality of life. P-values refer to differences for either log-transformed DQOL score or 










DQOL (46 items, score 46-230)  
 
78.2  (69-87) 75.5 (68-84) 81.5 (71-89) <0.001 
Diabetes impact (20 items, score 20-100) 
 
31.5 (27-36) 30.2 (27-33) 33.0 (28-37) <0.001 
Diabetes-related worries (4 items, score 4-20) 
 
7.1 (5-9) 6.5 (5-8) 7.9 (6-9) <0.001 
Satisfaction (15 items, score 15-75) 
 
30.2 (26-36) 29.7 (25-35) 30.7 (26-37) 0.23 
Social worries (7 items, score 7-35) 
 
8.6 (8-9) 8.4 (8-8) 8.9 (8-9) 0.041 
 
 
Table 2: Univariate analyses of characteristics of the adult population recruited by the T1DM Registry of Turin, by DQOL. Higher scores imply 





 N (%) DQOL p 
Hypertension                                                                             no 218 (70.3) 77.3 (68-86) 0.08 
yes 92 (29.7) 80.4 (70-91)  
Normoalbuminuria 254 (81.9) 77.6 (69-86) 0.08 
Micro-macroalbuminuria 56 (18.1) 81.2 (70-92)  
Peripheral neuropathy                                                             no 276 (89.0) 77.6 (69-86) 0.02 
yes 34 (11.0) 83.8 (70-96)  
Autonomic neuropathy                                                            no 258 (83.2) 77.3 (69-86) 0.01 
                                                                                                 yes 52 (16.8) 82.9 (72-92)  
Daily SMBG       (n)                                                                  0-4  82 (27.9%) 82.1 (71-92) 0.002 
>4 212 (72.10 76.4 (68-86)  
Diabetologic visits over the  previous year (n )                     0-2 46 (14.9) 83.0 (72-86) 0.016 
3 + 223 (71.9) 77.5 (68-88)  
Severe hypoglycemia                                                                no 240 (77.4) 77.1 (69-86) 0.007 
yes 70 (22.6) 82.3 (71-93)  
Schooling                                                              primary school 83 (26.8) 82.6 (71-92) 0.001 
               middle school and higher 227 (73.2) 76.7 (69-86)  
 
Table 3: Multivariate analysis of variables independently associated with DQOL among adults recruited by 
the T1DM Registry of Turin. Exponentiated β coefficients (95% confidence interval) from multivariate 
models. P values from Likelihood Ratio (LR) test for nested models. Higher scores imply worse QoL 
 
 
DQOL β (95% CI) P value 
Sex (females vs males) 1.07 (1.03-1.11) 0.003 
Age at onset (per 8 years) 1.03 (1.00-1.05) 0.009 
Schooling (primary school vs middle school and higher) 1.05 (1.00-1.09) 0.02 
Fasting plasma glucose (per 86 mg/dl) 1.03 (1.01-1.05) 0.008 
Daily SMBG (>4 vs ≤4) 1.06 (1.01-1.10) 0.01 
Severe hypoglycemic attack over previous year (yes vs no) 1.06 (1.01-1.11) 0.02 
Diabetologic visits over previous year (0-2 vs >2) 1.07 (1.01-1.13) 0.02 




Online Table 1: Univariate analyses of characteristics of the adult population recruited by the T1DM Registry of Turin, by DQOL subscales. Higher 













Hypertension                                    no 31.2 (27-35) 0.23 7.1 (5-9) 0.93 29.5 (25-35) 0.009 8.7 (8-9) 0.34 
yes 32.1 (28-36)  7.1 (6-8)  31.9 (27-38)  8.3 (8-8)  
Normoalbuminuria 31.2 (27-35) 0.07 7.1 (7-9) 0.81 29.9 (25-35) 0.11 8.6 (8-9) 0.80 
Micro-macroalbuminuria 32.9 (28-38)  7.2 (6-8)  31.6 (26-38)  8.6 (8-9)  
Retinopathy                                      no 31.1 (27-35) 0.25 7.0 (5-9) 0.29 29.6 (25-35) 0.10 8.6 (8-8) 0.77 
yes 31.9 (27-36)  7.3 (6-9)  30.9 (27-36)  8.6 (8-9)  
Peripheral neuropathy                    no 31.2 (27-35) 0.06 7.0 (5-9) 0.16 29.9 (25-35) 0.03 8.6 (8-9) 0.36 
yes 33.4 (28-37)  7.7 (6-10)  32.8 (26-42)  8.9 (8-9)  
Autonomic neuropathy                    no 31.0 (27-35) 0.005 7.1 (6-9) 0.53 29.9 (25-36) 0.12 8.5 (8-9) 0.06 
yes 33.8 (28-39)  7.3 (5-10)  31.6 (27-37)  9.1 (8-9)  
Daily SMBG       (n)                          0-4  30.6 (28-37) <0.001 7.6 (6-11) 0.008 30.9 (26-38) 0.19 9.0 (8-9) 0.04 
>4 33.5 (27-34)  6.9 (5-9)  29.6 (25-35)  8.5 (8-9)  
Diabetologic visits over the  previous 
year (n )                                            0-2 32.5 (28-36) 0.24 7.1 (6-9) 0.87 34.1 (30-38 <0.001 8.6 (8-9) 0.85 
3 + 31.3 (27-35)  7.1 (5-9)  29.5 (25-35)  8.6 (8-8)  
Hospitalizations                                no 31.0 (27-36) 0.25 7.1 (5-9) 0.79 30.3 (26-36) 0.83 8.7 (8-8)  
yes 31.8 (28-36)  7.1 (6-9)  30.1 (25-36)  8.7 (8-9) 0.59 
Severe hypoglycemia                        no 30.7 (27-34) <0.001 6.9 (5-8) 0.03 30.0 (25-36) 0.33 8.6 (8-8)  
yes 34.1 (28-39)  7.7 (6-10)  30.9 (27-36)  8.7 (8-9) 0.53 
Schooling               primary school 33.4 (28-39) 0.001 7.5 (6-10) 0.06 32.1 (27-38) 0.007 8.5 (8-8) 0.71 
               middle school and higher 30.8 (27-34)  6.9 (5-9)  30.2 (25-35)  8.7 (8-9)  
 
 
Online Table 2: Multivariate analysis of variables independently associated with DQOL subscales among adults recruited by the T1DM Registry of 
Turin. Exponentiated β coefficients (95% confidence interval) from multivariate models. P values from Likelihood Ratio (LR) test for nested models. 
Higher scores imply worse QoL 
 
      Diabetes impact   
       Sex (females vs males) 1.07 (1.03-1.12) <0.001 
 
       Age at onset (per 8 years) 1.03 (1.01-1.05) 0.003 
       Schooling (primary school vs middle school and higher) 1.05 (1.00-1.10) 0.05 
       Fasting plasma glucose (per 86 mg/dl) 1.02 (1.00-1.05) 0.02 
       Daily SMBG (>4 vs ≤4) 1.07 (1.02-1.13) 0.003 
       Severe hypoglycemic attack over previous year (yes vs no) 1.09 (1.04-1.15) 0.005 
       Hypertension (yes vs no) 1.05 (1.01-1.10) 0.03 
       Autonomic neuropathy (yes vs no) 1.07 (1.00-1.13) 0.03 
Diabetes-related worries   
       Sex (females vs males) 4.36 (2.43-7.83) <0.001 
       Daily SMBG (>4 vs ≤4) 3.77 (1.72-8.30) <0.001 
       CSII (yes vs no) 0.22 (0.07-0.68) 0.008 
Satisfaction   
       Age at onset (per 8 years) 1.03 (1.00-1.06) 0.02 
Schooling (primary school vs middle school and higher) 1.08 (1.02-1.15) 0.005 
       Fasting plasma glucose (per 86 mg/dl) 1.04 (1.01-1.06) 0.006 
Diabetologic visits over previous previous year (≤ 2 vs >2) 1.15 (1.07-1.23) <0.001 
       Hypertension (yes vs no) 1.09 (1.03-1.15) 0.005 
Social worries   
Age (per 7 years) 0.97 (0.95-0.99) 0.02 
Daily SMBG (>4 vs ≤4) 1.06 (1.00-1.12) 0.04 
Autonomic neuropathy (yes vs no) 1.09 (1.01-1.17) 0.02 
 
 
